UNSPSC 85433809: The diagnosis of poisoning by antivaricose drugs, including sclerosing agents

In this classification, this covers the group of activities that yields a diagnosis of poisoning: Antivaricose drugs, including sclerosing agents. Poisoning: Antivaricose drugs, including sclerosing agents is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code T46.8.

UNSPSC 85433809, The diagnosis of poisoning by antivaricose drugs, including sclerosing agents, is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's clinical focus — diagnosis of specific drug poisonings — does not align with the three posted opportunities, which instead address diagnostic imaging systems, special education services, and temporary health professional staffing. The opportunities do not involve antivaricose drugs, sclerosing agents, or poisoning diagnosis at any level. This code shows little relevant recent activity for firms pursuing work under its stated description.

The posted opportunities that carry this code tag span health system diagnostic infrastructure, school district services, and staffing placement — none of which relate to the code's nominal scope. San Mateo Medical Center issued an RFP for a PACS (Picture Archiving and Communication System) with a due date of October 21, 2026; Birdville Independent School District in Texas issued a competitive sealed proposal for special education contracted services due October 21, 2026; and Santa Clara County Health System issued an RFQ to establish a qualified vendor pool for temporary health professional staffing with a due date of October 7, 2026. The geographic spread reflects California and Texas activity, but the code category itself does not provide actionable procurement intelligence for vendors in toxicology, clinical chemistry, or poison control services.